lidocaine has been researched along with Brugada ECG Pattern in 45 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We demonstrate that lidocaine may suppress Brugada syndrome associated with the N406S mutation by preventing the sodium channel from accumulating in the intermediate inactivation state." | 7.74 | A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. ( Ashihara, T; Horie, M; Imoto, K; Ito, M; Itoh, H; Jo, H; Nagaoka, I; Nakazawa, Y; Oka, Y; Sakaguchi, T; Tsuji, K; Yao, T, 2007) |
| "Pilsicainide induced VA in some patients with Brugada syndrome, but this result may not be used as a parameter of the risk stratification of Brugada syndrome." | 7.74 | Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Komura, S; Tanabe, Y; Washizuka, T, 2007) |
| "Brugada syndrome has been linked to mutations in SCN5A." | 5.35 | Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. ( Antzelevitch, C; Barajas-Martínez, HM; Brugada, R; Cordeiro, JM; Dumaine, R; Elena, B; Hu, D; Kovacs, RJ; Kui, H; Meltser, H; Wu, Y, 2008) |
| " We investigated the association between spontaneous ventricular fibrillation (VF) occurrence and TWA after pilsicainide, a sodium channel blocker administration in BS patients." | 5.13 | Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. ( Banba, K; Kusano, KF; Miura, D; Morita, H; Nagase, S; Nakamura, K; Nishii, N; Ohe, T; Tada, T; Watanabe, A, 2008) |
| "We administered intravenous pilsicainide to 245 consecutive patients with Brugada syndrome (181 patients with spontaneous type 1 ECG, 64 patients with non-type 1 ECG)." | 3.88 | Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome. ( Ito, H; Kawada, S; Miyamoto, M; Morimoto, Y; Morita, H; Nakagawa, K; Nishii, N; Tachibana, M; Ueoka, A; Watanabe, A, 2018) |
| "Administration of pilsicainide, a class IC antiarrhythmic agent, caused Brugada- type ST elevation in a 66-year-old Japanese male who presented with paroxysmal atrial fibrillation (PAF), type I atrial flutter and inducible ventricular fibrillation (VF) during electrophysiological study." | 3.83 | A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG. ( Ai, T; Horie, M; Itoh, H; Makiyama, T; Shimizu, A; Turker, I; Ueyama, T; Vatta, M, 2016) |
| "We demonstrate that lidocaine may suppress Brugada syndrome associated with the N406S mutation by preventing the sodium channel from accumulating in the intermediate inactivation state." | 3.74 | A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. ( Ashihara, T; Horie, M; Imoto, K; Ito, M; Itoh, H; Jo, H; Nagaoka, I; Nakazawa, Y; Oka, Y; Sakaguchi, T; Tsuji, K; Yao, T, 2007) |
| "Pilsicainide induced VA in some patients with Brugada syndrome, but this result may not be used as a parameter of the risk stratification of Brugada syndrome." | 3.74 | Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Komura, S; Tanabe, Y; Washizuka, T, 2007) |
| " Routine use of intravenous sodium bicarbonate is recommended to combat the severe metabolic acidosis accompanying cardiac arrest." | 3.64 | THE CHEMOTHERAPY OF CARDIAC ARREST. ( MINUCK, M, 1965) |
| " We hypothesized that the use of local dental anesthesia with lidocaine with and without epinephrine is safe and does not result in life-threatening arrhythmias in patients with channelopathies." | 2.90 | Is It Safe for Patients With Cardiac Channelopathies to Undergo Routine Dental Care? Experience From a Single-Center Study. ( Barbosa, SA; Carvalho, CMA; Darrieux, FCC; Grupi, CJ; Hachul, DT; Montano, TCP; Neves, ILI; Neves, RS; Oliveira, ACG; Olivetti, NQS; Pastore, CA; Sacilotto, L; Samesima, N; Santos-Paul, MAD; Scanavacca, MI; Wu, TC, 2019) |
| "Brugada syndrome has been linked to mutations in SCN5A." | 1.35 | Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. ( Antzelevitch, C; Barajas-Martínez, HM; Brugada, R; Cordeiro, JM; Dumaine, R; Elena, B; Hu, D; Kovacs, RJ; Kui, H; Meltser, H; Wu, Y, 2008) |
| "Frequent premature ventricular complexes (PVCs) with two different left bundle branch block patterns developed during ST segment elevation." | 1.35 | Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Tagawa, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (46.67) | 29.6817 |
| 2010's | 18 (40.00) | 24.3611 |
| 2020's | 3 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksandrowicz, D | 1 |
| Hasebe, H | 1 |
| Yokoya, T | 1 |
| Murakoshi, N | 1 |
| Kurebayashi, N | 1 |
| Loiudice, P | 1 |
| Monitillo, F | 1 |
| Nardi, M | 1 |
| Iacoviello, M | 1 |
| Casini, G | 1 |
| Kakihara, J | 1 |
| Takagi, M | 3 |
| Hayashi, Y | 1 |
| Tatsumi, H | 3 |
| Doi, A | 3 |
| Yoshiyama, M | 3 |
| Ueoka, A | 1 |
| Morita, H | 5 |
| Watanabe, A | 3 |
| Morimoto, Y | 1 |
| Kawada, S | 1 |
| Tachibana, M | 1 |
| Miyamoto, M | 1 |
| Nakagawa, K | 1 |
| Nishii, N | 3 |
| Ito, H | 1 |
| Nagayama, T | 1 |
| Nagase, S | 3 |
| Kamakura, T | 2 |
| Wada, M | 2 |
| Ishibashi, K | 2 |
| Inoue, YY | 1 |
| Miyamoto, K | 2 |
| Noda, T | 2 |
| Aiba, T | 2 |
| Takaki, H | 2 |
| Sugimachi, M | 1 |
| Shimizu, W | 2 |
| Noguchi, T | 1 |
| Yasuda, S | 2 |
| Kamakura, S | 2 |
| Kusano, K | 2 |
| Oliveira, ACG | 1 |
| Neves, ILI | 1 |
| Sacilotto, L | 1 |
| Olivetti, NQS | 1 |
| Santos-Paul, MAD | 1 |
| Montano, TCP | 1 |
| Carvalho, CMA | 1 |
| Wu, TC | 1 |
| Grupi, CJ | 1 |
| Barbosa, SA | 1 |
| Pastore, CA | 1 |
| Samesima, N | 1 |
| Hachul, DT | 1 |
| Scanavacca, MI | 1 |
| Neves, RS | 1 |
| Darrieux, FCC | 1 |
| Nakajima, I | 1 |
| Okamura, H | 1 |
| Ogawa, H | 1 |
| Makiyama, T | 2 |
| Kimura, T | 1 |
| Yamasaki, H | 1 |
| Tada, H | 1 |
| Sekiguchi, Y | 2 |
| Aonuma, K | 1 |
| Wang, HG | 1 |
| Zhu, W | 1 |
| Kanter, RJ | 1 |
| Silva, JR | 1 |
| Honeywell, C | 1 |
| Gow, RM | 1 |
| Pitt, GS | 1 |
| Turker, I | 1 |
| Vatta, M | 1 |
| Itoh, H | 2 |
| Ueyama, T | 5 |
| Shimizu, A | 4 |
| Ai, T | 1 |
| Horie, M | 2 |
| Barajas-Martínez, HM | 1 |
| Hu, D | 1 |
| Cordeiro, JM | 1 |
| Wu, Y | 1 |
| Kovacs, RJ | 1 |
| Meltser, H | 1 |
| Kui, H | 1 |
| Elena, B | 1 |
| Brugada, R | 1 |
| Antzelevitch, C | 1 |
| Dumaine, R | 1 |
| Fozzard, HA | 1 |
| Sánchez Ortega, JL | 1 |
| González Pérez, P | 1 |
| Escribano Jiménez, M | 1 |
| Kofune, M | 2 |
| Watanabe, I | 2 |
| Ashino, S | 2 |
| Ohkubo, K | 2 |
| Okumura, Y | 2 |
| Kofune, T | 1 |
| Nakai, T | 2 |
| Hirayama, A | 2 |
| Omichi, C | 1 |
| Fujimoto, N | 1 |
| Kawasaki, A | 1 |
| Kasai, A | 1 |
| Chinushi, M | 2 |
| Tagawa, M | 1 |
| Izumi, D | 2 |
| Furushima, H | 2 |
| Aizawa, Y | 2 |
| Shimeno, K | 2 |
| Maeda, K | 2 |
| Nakagawa, E | 1 |
| Mizobuchi, M | 1 |
| Enjoji, Y | 1 |
| Nakamura, S | 1 |
| Muranishi, H | 1 |
| Utsunomiya, M | 1 |
| Funatsu, A | 1 |
| Kobayashi, T | 1 |
| Ogawa, R | 1 |
| Kishi, R | 2 |
| Takagi, A | 2 |
| Sakaue, I | 1 |
| Takahashi, H | 1 |
| Matsumoto, N | 1 |
| Masuhara, K | 1 |
| Nakazawa, K | 2 |
| Kobayashi, S | 1 |
| Miyake, F | 2 |
| Echizen, H | 1 |
| Zipes, DP | 2 |
| Morita, ST | 2 |
| Wu, J | 2 |
| Sugi, N | 3 |
| Yoshiga, Y | 3 |
| Doi, M | 1 |
| Ohmiya, T | 1 |
| Ohno, M | 1 |
| Yoshida, M | 1 |
| Matsuzaki, M | 4 |
| Hisada, T | 1 |
| Miyagawa, T | 1 |
| Yakushiji, T | 1 |
| Tsujimoto, T | 1 |
| Sakai, M | 1 |
| Adachi, T | 1 |
| Ikewaki, K | 1 |
| Ogata, K | 1 |
| Ohsuzu, F | 1 |
| Sakurai, Y | 1 |
| Nagashima, K | 1 |
| Kunimoto, S | 1 |
| Kasamaki, Y | 1 |
| Murata, K | 1 |
| Tanaka, T | 1 |
| Nose, Y | 1 |
| Wada, Y | 1 |
| Ripley, A | 1 |
| Castro, J | 1 |
| Gadsden, J | 1 |
| VAN DONGEN, K | 1 |
| MINUCK, M | 1 |
| NAVARIVERA, A | 1 |
| VEGAESQUIVEL, E | 1 |
| LOPEZ, AJ | 1 |
| Ikeda, T | 1 |
| Abe, A | 1 |
| Yusu, S | 1 |
| Nakamura, K | 3 |
| Ishiguro, H | 1 |
| Mera, H | 1 |
| Yotsukura, M | 1 |
| Yoshino, H | 1 |
| Yodogawa, K | 1 |
| Morita, N | 1 |
| Kobayashi, Y | 1 |
| Takayama, H | 1 |
| Ohara, T | 1 |
| Katoh, T | 1 |
| Takano, T | 1 |
| Yamagata, T | 1 |
| Esato, M | 2 |
| Ohmura, M | 1 |
| Kanemoto, M | 1 |
| Kametani, R | 1 |
| Sawa, A | 2 |
| Suzuki, S | 2 |
| Deschênes, I | 1 |
| Laurita, KR | 1 |
| Sakurai, T | 1 |
| Osada, K | 1 |
| Ryu, S | 1 |
| Fujita, S | 1 |
| Matsuda, H | 1 |
| Ishikawa, Y | 1 |
| Tsuji, K | 1 |
| Sakaguchi, T | 1 |
| Nagaoka, I | 1 |
| Oka, Y | 1 |
| Nakazawa, Y | 1 |
| Yao, T | 1 |
| Jo, H | 1 |
| Ashihara, T | 1 |
| Ito, M | 1 |
| Imoto, K | 1 |
| Komura, S | 1 |
| Tanabe, Y | 1 |
| Washizuka, T | 1 |
| Yoshisato, T | 1 |
| Takeda, H | 1 |
| Tsuburaya, R | 1 |
| Endo, N | 1 |
| Niitsuma, T | 1 |
| Miura, E | 1 |
| Hirosaka, A | 1 |
| Owada, K | 1 |
| Tamagawa, K | 1 |
| Clancy, CE | 1 |
| Wehrens, XH | 1 |
| Tada, T | 1 |
| Kusano, KF | 2 |
| Banba, K | 2 |
| Miura, D | 1 |
| Ohe, T | 2 |
| Kanemori, T | 1 |
| Shimizu, H | 1 |
| Oka, K | 1 |
| Furukawa, Y | 1 |
| Hiromoto, K | 1 |
| Mine, T | 1 |
| Masuyama, T | 1 |
| Ohyanagi, M | 1 |
| Madias, JE | 1 |
| Hiramatsu, S | 1 |
| Sakuragi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies[NCT03182777] | 31 participants (Actual) | Interventional | 2015-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lidocaine and Brugada ECG Pattern
| Article | Year |
|---|---|
[Brugada syndrome, bupivacaine, lidocaine, and techniques to provide local or regional anesthesia: comments on "Ventricular fibrillation in a patient with a type I Brugada syndrome ECG pattern and hypokalemia"].
Topics: Anesthesia, Conduction; Anesthetics, Local; Brugada Syndrome; Bupivacaine; Female; Humans; Hypokalem | 2008 |
5 trials available for lidocaine and Brugada ECG Pattern
| Article | Year |
|---|---|
Is It Safe for Patients With Cardiac Channelopathies to Undergo Routine Dental Care? Experience From a Single-Center Study.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Brugada Syndrome; Channelopathies; Contraindications, P | 2019 |
Different effect of the pure Na+ channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function.
Topics: Adult; Aged; Algorithms; Brugada Syndrome; Electrocardiography; Female; Heart Diseases; Humans; Lido | 2007 |
Discrimination of Brugada syndrome patients from individuals with the saddle-back type ST-segment elevation using a marker of the standard 12-lead electrocardiography.
Topics: Adult; Aged; Arrhythmias, Cardiac; Biomarkers; Brugada Syndrome; Diagnosis, Differential; Electrocar | 2007 |
Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
Topics: Brugada Syndrome; Electrocardiography; Female; Humans; Lidocaine; Male; Middle Aged; Sodium Channel | 2008 |
Sodium channel blockers enhance the temporal QT interval variability in the right precordial leads in Brugada syndrome.
Topics: Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; H | 2008 |
39 other studies available for lidocaine and Brugada ECG Pattern
| Article | Year |
|---|---|
Amiodarone or lidocaine, that is the question - Pharmacological therapy of refractory ventricular fibrillation associated with Brugada syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Humans; Lidocaine; Ventricular Fibrillation | 2021 |
Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Lidocaine; Long QT Syn | 2020 |
Local peribulbar anesthesia before glaucoma filtering surgery in a patient with Brugada syndrome.
Topics: Aged; Anesthesia, Local; Anesthetics, Local; Blood Pressure; Brugada Syndrome; Electrocardiography; | 2021 |
Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography, Ambulatory; Female; Humans; Lidocaine | 2017 |
Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
Topics: Administration, Intravenous; Adult; Aged; Brugada Syndrome; Death, Sudden, Cardiac; Electrocardiogra | 2018 |
Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Female; Humans; Lidocaine; Mal | 2019 |
Significance of electrocardiogram recording in high intercostal spaces in patients with early repolarization syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, | 2016 |
Right coronary cusp as a new window of ablation for pilsicainide-induced ventricular premature contractions in a patient with Brugada syndrome.
Topics: Adult; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Ventricl | 2016 |
A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; | 2016 |
A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Base Sequence; Brugada Syndrome; | 2016 |
Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
Topics: Anesthetics, Local; Brugada Syndrome; Electrocardiography; Humans; Lidocaine; Male; Middle Aged; Mus | 2008 |
Increased sensitivity to local anesthetic drugs: bedside to bench.
Topics: Anesthetics, Local; Brugada Syndrome; Electrocardiography; Humans; Lidocaine; Mutation, Missense; So | 2008 |
Action potential alternans in the right ventricular outflow tract in a patient with asymptomatic Brugada syndrome.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Lido | 2009 |
Ischemia-induced Brugada-type ST-segment alternans and Brugada syndrome.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Brugada Syndrome; Bundle-Branch Block; Coronary Artery | 2010 |
Pilsicainide-induced ST segment elevation and ST segment depression in two patients with variant forms of Brugada-type electrocardiographic abnormalities.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Injections | 2009 |
A predictor of positive drug provocation testing in individuals with saddle-back type ST-segment elevation.
Topics: Action Potentials; Adult; Brugada Syndrome; Electrocardiography; Female; Humans; Infusions, Intraven | 2009 |
Ventricular late potential in patients with apparently normal electrocardiogram; predictor of Brugada syndrome.
Topics: Adult; Aged; Aged, 80 and over; Brugada Syndrome; Chi-Square Distribution; Electrocardiography; Fema | 2010 |
Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Coronary Sinus; Death, Sudden, Cardiac; Electrocard | 2010 |
A novel microsatellite polymorphism of sodium channel beta1-subunit gene (SCN1B) may underlie abnormal cardiac excitation manifested by coved-type ST-elevation compatible with Brugada syndrome in Japanese.
Topics: Adult; Age Factors; Aged; Asian People; Brugada Syndrome; Electrocardiography; Female; Genetic Predi | 2010 |
Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Body Surface Potential | 2010 |
What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease?
Topics: Brugada Syndrome; Electric Stimulation; Electrocardiography; Female; Humans; Lidocaine; Male; Middle | 2010 |
Ventricular fibrillation diagnosed during electrophysiological study for non-sustained tachycardia.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Japan; Lidocaine; Male | 2010 |
A new criteria differentiating type 2 and 3 Brugada patterns from ordinary incomplete right bundle branch block.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Bundle-Branch Block; Diagnosis, Differential; Elect | 2011 |
Right ventricular dysfunction in patients with Brugada-like electrocardiography: a two dimensional strain imaging study.
Topics: Brugada Syndrome; Echocardiography; Elasticity Imaging Techniques; Electrocardiography; Female; Huma | 2011 |
Local anesthetics, neuraxial anesthesia, and the Brugada syndrome.
Topics: Anesthesia, Conduction; Anesthetics, Local; Asthma; Brugada Syndrome; Humans; Intestine, Small; Lido | 2013 |
The action of xylocaine on fibrillation of the heart.
Topics: Anesthetics; Anesthetics, Local; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System D | 1953 |
THE CHEMOTHERAPY OF CARDIAC ARREST.
Topics: Acidosis; Arrhythmias, Cardiac; Bicarbonates; Brugada Syndrome; Cardiac Conduction System Disease; C | 1965 |
[COUNTEREFFECT OF LOCAL BLOCKING AGENTS ON CARDIAC ARRHYTHMIA].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Complexes, Premature; Cardiac Conduction System Dise | 1965 |
The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
Topics: Adult; Brugada Syndrome; Circadian Rhythm; Electrocardiography; Electrophysiologic Techniques, Cardi | 2006 |
High-frequency potentials developed in wavelet-transformed electrocardiogram as a novel indicator for detecting Brugada syndrome.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Brugada Syndrome; | 2006 |
Temperature modulation of ventricular arrhythmogenicity in a canine tissue model of Brugada syndrome.
Topics: Action Potentials; Animals; Body Temperature; Brugada Syndrome; Disease Models, Animal; Dogs; Electr | 2007 |
How can a single mutation cause such arrhythmic havoc?
Topics: Action Potentials; Animals; Body Temperature; Brugada Syndrome; Disease Models, Animal; Dogs; Electr | 2007 |
A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Computer Simulation; Genetic Predisposition to Disease; Hu | 2007 |
Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
Topics: Adult; Aged; Arrhythmias, Cardiac; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniq | 2007 |
[Elderly Brugada syndrome with recurrent syncope, diagnosed by pilsicainide challenge test].
Topics: Aged; Brugada Syndrome; Electrocardiography; Humans; Lidocaine; Male; Recurrence; Syncope | 2007 |
Mutation-specific effects of lidocaine in Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Genetic Predisposition to Disease; Humans; Lidocaine; Musc | 2007 |
Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Catheter Ablation; Electrocardiography; Electrophysiologic | 2008 |
Re: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
Topics: Brugada Syndrome; Electrocardiography; Female; Humans; Lidocaine; Male; Middle Aged; Sodium Channel | 2008 |
Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
Topics: Action Potentials; Adult; Aged; Brugada Syndrome; Case-Control Studies; Electrocardiography; Endocar | 2008 |